Thomas Weisel Initiates Coverage on Endo Pharmaceuticals (ENDP) with an Overweight
Tweet Send to a Friend
Thomas Weisel initiates coverage on Endo Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
